Skip to main content
Top
Published in: Nutrition & Metabolism 1/2012

Open Access 01-12-2012 | Research

Hydroxypropyl methylcellulose, a viscous soluble fiber, reduces insulin resistance and decreases fatty liver in Zucker Diabetic Fatty rats

Authors: David A Brockman, Xiaoli Chen, Daniel D Gallaher

Published in: Nutrition & Metabolism | Issue 1/2012

Login to get access

Abstract

Background

Diets producing a high glycemic response result in exaggerated insulin secretion which induces hepatic lipogenesis, contributing to development of insulin resistance and fatty liver. Viscous dietary fibers blunt the postprandial rise in blood glucose, however their effect on type 2 diabetes and obesity are not entirely known. This study examined the effect of chronic consumption of the viscous, non-fermentable dietary fiber, hydroxypropyl methylcellulose (HPMC), on glucose control, insulin resistance and liver lipids in an obese diabetic rat model.

Methods

Three groups of Zucker Diabetic Fatty (ZDF) rats were fed diets containing either 5% non-viscous cellulose (control), low viscosity HPMC (LV-HPMC) or high viscosity HPMC (HV- HPMC) for six weeks. Zucker lean littermates consuming cellulose served as a negative control. Markers of glucose control, including oral glucose tolerance test, glycated hemoglobin and urinary glucose, were measured as well as adiposity and the accumulation of liver lipids.

Results

The HPMC diets increased the viscosity of the small intestinal contents and reduced the postprandial rise in blood glucose. The food efficiency ratio was greater with HPMC feeding compared to the obese control and urinary excretion of glucose and ketone bodies was reduced. The two HPMC groups had lower glycated hemoglobin and kidney weights and a reduced area under the curve during a glucose tolerance test, indicating improved glucose control. Epididymal fat pad weight as percent of body weight was reduced in the HV-HPMC group compared to the obese control group. The HV-HPMC group also had lower concentrations of liver lipid and cholesterol and reduced liver weight. However, HV-HPMC feeding did not affect hepatic gene expression of SREBP-1c or FAS. Muscle concentration of acylcarnitines, a lipid intermediate in fatty acid β-oxidation, was not different between the HPMC groups and obese control, suggesting no change in muscle fatty acid oxidation by HPMC.

Conclusions

Consumption of the viscous non-fermentable fiber HPMC decreased diabetic wasting, improved glucose control and reduced insulin resistance and fatty liver in a model of obesity with diabetes.
Appendix
Available only for authorised users
Literature
2.
go back to reference Marchesini G, Marzocchi R, Agostini F, Bugianesi E: Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol. 2005, 16: 421-427. 10.1097/01.mol.0000174153.53683.f2.CrossRef Marchesini G, Marzocchi R, Agostini F, Bugianesi E: Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol. 2005, 16: 421-427. 10.1097/01.mol.0000174153.53683.f2.CrossRef
3.
go back to reference Farrell GC, Larter CZ: Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006, 43: S99-S112. 10.1002/hep.20973.CrossRef Farrell GC, Larter CZ: Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006, 43: S99-S112. 10.1002/hep.20973.CrossRef
4.
go back to reference Pawlak D, Kushner J, Ludwig D: Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals. Lancet. 2004, 364: 778-785. 10.1016/S0140-6736(04)16937-7.CrossRef Pawlak D, Kushner J, Ludwig D: Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals. Lancet. 2004, 364: 778-785. 10.1016/S0140-6736(04)16937-7.CrossRef
5.
go back to reference Rizkalla SW, Taghrid L, Laromiguiere M, Huet D, Boillot J, Rigoir A, Elgrably F, Slama G: Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial. Diabetes Care. 2004, 27: 1866-1872. 10.2337/diacare.27.8.1866.CrossRef Rizkalla SW, Taghrid L, Laromiguiere M, Huet D, Boillot J, Rigoir A, Elgrably F, Slama G: Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial. Diabetes Care. 2004, 27: 1866-1872. 10.2337/diacare.27.8.1866.CrossRef
6.
go back to reference Bouche C, Rizkalla SW, Luo J, Vidal H, Veronese A, Pacher N, Fouquet C, Lang V, Slama G: Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care. 2002, 25: 822-828. 10.2337/diacare.25.5.822.CrossRef Bouche C, Rizkalla SW, Luo J, Vidal H, Veronese A, Pacher N, Fouquet C, Lang V, Slama G: Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care. 2002, 25: 822-828. 10.2337/diacare.25.5.822.CrossRef
7.
go back to reference Isken F, Klaus S, Petzke KJ, Loddenkemper C, Pfeiffer AF, Weickert MO: Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype. Am J Physiol Endocrinol Metab. 2010, 298: E287-E295. 10.1152/ajpendo.00515.2009.CrossRef Isken F, Klaus S, Petzke KJ, Loddenkemper C, Pfeiffer AF, Weickert MO: Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype. Am J Physiol Endocrinol Metab. 2010, 298: E287-E295. 10.1152/ajpendo.00515.2009.CrossRef
8.
go back to reference Jenkins DJ, Leeds AR, Gassull MA, Cochet B, Alberti GM: Decrease in postprandial insulin and glucose concentrations by guar and pectin. Ann Intern Med. 1977, 86: 20-23.CrossRef Jenkins DJ, Leeds AR, Gassull MA, Cochet B, Alberti GM: Decrease in postprandial insulin and glucose concentrations by guar and pectin. Ann Intern Med. 1977, 86: 20-23.CrossRef
9.
go back to reference Pastors JG, Blaisdell PW, Balm TK, Asplin CM, Pohl SL: Psyllium fiber reduces rise in postprandial glucose and insulin concentrations in patients with non-insulin-dependent diabetes. Am J Clin Nutr. 1991, 53: 1431-1435. Pastors JG, Blaisdell PW, Balm TK, Asplin CM, Pohl SL: Psyllium fiber reduces rise in postprandial glucose and insulin concentrations in patients with non-insulin-dependent diabetes. Am J Clin Nutr. 1991, 53: 1431-1435.
10.
go back to reference Maki KC, Carson ML, Miller MP, Turowski M, Bell M, Wilder DM, Reeves MS: High-viscosity hydroxypropylmethylcellulose blunts postprandial glucose and insulin responses. Diabetes Care. 2007, 30: 1039-1043. 10.2337/dc06-2344.CrossRef Maki KC, Carson ML, Miller MP, Turowski M, Bell M, Wilder DM, Reeves MS: High-viscosity hydroxypropylmethylcellulose blunts postprandial glucose and insulin responses. Diabetes Care. 2007, 30: 1039-1043. 10.2337/dc06-2344.CrossRef
11.
go back to reference Leclere CJ, Champ M, Boillot J, Guille G, Lecannu G, Molis C, Bornet F, Krempf M, Delort-Laval J, Galmiche JP: Role of viscous guar gums in lowering the glycemic response after a solid meal. Am J Clin Nutr. 1994, 59: 914-921. Leclere CJ, Champ M, Boillot J, Guille G, Lecannu G, Molis C, Bornet F, Krempf M, Delort-Laval J, Galmiche JP: Role of viscous guar gums in lowering the glycemic response after a solid meal. Am J Clin Nutr. 1994, 59: 914-921.
12.
go back to reference McDonald MHDaA: Fiber: forms and functions. Nutrition Res. 1998, 18: 617-624. 10.1016/S0271-5317(98)00048-7.CrossRef McDonald MHDaA: Fiber: forms and functions. Nutrition Res. 1998, 18: 617-624. 10.1016/S0271-5317(98)00048-7.CrossRef
13.
go back to reference Dumoulin V, Moro F, Barcelo A, Dakka T, Cuber JC: Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum. Endocrinology. 1998, 139: 3780-3786. 10.1210/en.139.9.3780.CrossRef Dumoulin V, Moro F, Barcelo A, Dakka T, Cuber JC: Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum. Endocrinology. 1998, 139: 3780-3786. 10.1210/en.139.9.3780.CrossRef
14.
go back to reference Cherbut C, Ferrier L, Roze C, Anini Y, Blottiere H, Lecannu G, Galmiche JP: Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol. 1998, 275: G1415-G1422. Cherbut C, Ferrier L, Roze C, Anini Y, Blottiere H, Lecannu G, Galmiche JP: Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol. 1998, 275: G1415-G1422.
15.
go back to reference Dass NB, John AK, Bassil AK, Crumbley CW, Shehee WR, Maurio FP, Moore GB, Taylor CM, Sanger GJ: The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation. Neurogastroenterol Motil. 2007, 19: 66-74. 10.1111/j.1365-2982.2006.00853.x.CrossRef Dass NB, John AK, Bassil AK, Crumbley CW, Shehee WR, Maurio FP, Moore GB, Taylor CM, Sanger GJ: The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation. Neurogastroenterol Motil. 2007, 19: 66-74. 10.1111/j.1365-2982.2006.00853.x.CrossRef
16.
go back to reference Reeves PG, Nielsen FH, Fahey GC: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993, 123: 1939-1951. Reeves PG, Nielsen FH, Fahey GC: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993, 123: 1939-1951.
17.
go back to reference Islam A, Civitarese AE, Hesslink RL, Gallaher DD: Viscous dietary fiber reduces adiposity and plasma leptin and increases muscle expression of fat oxidation genes in rats. Obesity (Silver Spring). 2012, 20: 349-355. 10.1038/oby.2011.341.CrossRef Islam A, Civitarese AE, Hesslink RL, Gallaher DD: Viscous dietary fiber reduces adiposity and plasma leptin and increases muscle expression of fat oxidation genes in rats. Obesity (Silver Spring). 2012, 20: 349-355. 10.1038/oby.2011.341.CrossRef
18.
go back to reference Muniyappa R, Lee S, Chen H, Quon MJ: Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008, 294: E15-E26.CrossRef Muniyappa R, Lee S, Chen H, Quon MJ: Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008, 294: E15-E26.CrossRef
19.
go back to reference Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957, 226: 497-509. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957, 226: 497-509.
20.
go back to reference Gallaher DD, Hassel CA, Lee KJ, Gallaher CM: Viscosity and fermentability as attributes of dietary fiber responsible for the hypocholesterolemic effect in hamsters. J Nutr. 1993, 123: 244-252. Gallaher DD, Hassel CA, Lee KJ, Gallaher CM: Viscosity and fermentability as attributes of dietary fiber responsible for the hypocholesterolemic effect in hamsters. J Nutr. 1993, 123: 244-252.
21.
go back to reference Morin LG, Prox J: Single glucose oxidase-peroxidase reagent for two-minute determination of serum glucose. Clin Chem. 1973, 19: 959-962. Morin LG, Prox J: Single glucose oxidase-peroxidase reagent for two-minute determination of serum glucose. Clin Chem. 1973, 19: 959-962.
22.
go back to reference Lee HS, Shoeman DW, Csallany AS: Urinary response to in vivo lipid peroxidation induced by vitamin E deficiency. Lipids. 1992, 27: 124-128. 10.1007/BF02535811.CrossRef Lee HS, Shoeman DW, Csallany AS: Urinary response to in vivo lipid peroxidation induced by vitamin E deficiency. Lipids. 1992, 27: 124-128. 10.1007/BF02535811.CrossRef
23.
go back to reference Yang S, Minkler P, Hoppel C: cis-3,4-Methylene-heptanoylcarnitine: characterization and verification of the C8:1 acylcarnitine in human urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2007, 857: 251-258. 10.1016/j.jchromb.2007.07.027.CrossRef Yang S, Minkler P, Hoppel C: cis-3,4-Methylene-heptanoylcarnitine: characterization and verification of the C8:1 acylcarnitine in human urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2007, 857: 251-258. 10.1016/j.jchromb.2007.07.027.CrossRef
24.
go back to reference Gallaher DD, Olson JM, Larntz K: Dietary guar gum halts further renal enlargement in rats with established diabetes. J Nutr. 1992, 122: 2391-2397. Gallaher DD, Olson JM, Larntz K: Dietary guar gum halts further renal enlargement in rats with established diabetes. J Nutr. 1992, 122: 2391-2397.
25.
go back to reference Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW, Kang L, Rabinovitch PS, Szeto HH: Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest. 2009, 119: 573-581. 10.1172/JCI37048.CrossRef Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW, Kang L, Rabinovitch PS, Szeto HH: Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest. 2009, 119: 573-581. 10.1172/JCI37048.CrossRef
26.
go back to reference Rabe K, Lehrke M: Adipokines and insulin resistance. Molecular Medicine. 2008, 14: 1-CrossRef Rabe K, Lehrke M: Adipokines and insulin resistance. Molecular Medicine. 2008, 14: 1-CrossRef
27.
go back to reference Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M: Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab. 2007, 92: 2665-2671. 10.1210/jc.2006-2614.CrossRef Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M: Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab. 2007, 92: 2665-2671. 10.1210/jc.2006-2614.CrossRef
28.
go back to reference Vegiopoulos A, Herzig S: Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrin. 2007, 275: 43-61. 10.1016/j.mce.2007.05.015.CrossRef Vegiopoulos A, Herzig S: Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrin. 2007, 275: 43-61. 10.1016/j.mce.2007.05.015.CrossRef
29.
go back to reference Samuel VT, Beddow SA, Iwasaki T, Zhang XM, Chu X, Still CD, Gerhard GS, Shulman GI: Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes. Proc Natl Acad Sci U S A. 2009, 106: 12121-12126. 10.1073/pnas.0812547106.CrossRef Samuel VT, Beddow SA, Iwasaki T, Zhang XM, Chu X, Still CD, Gerhard GS, Shulman GI: Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes. Proc Natl Acad Sci U S A. 2009, 106: 12121-12126. 10.1073/pnas.0812547106.CrossRef
30.
go back to reference De Ceuninck F, Rolin JO, Caliez A, Baschet L, Ktorza A: Metabolic imbalance of the insulin-like growth factor-I axis in Zucker diabetic fatty rats. Metabolism. 2011, 60: 1575-1583. 10.1016/j.metabol.2011.03.012.CrossRef De Ceuninck F, Rolin JO, Caliez A, Baschet L, Ktorza A: Metabolic imbalance of the insulin-like growth factor-I axis in Zucker diabetic fatty rats. Metabolism. 2011, 60: 1575-1583. 10.1016/j.metabol.2011.03.012.CrossRef
31.
go back to reference Ferre P, Foufelle F: Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab. 2010, 12 (Suppl 2): 83-92.CrossRef Ferre P, Foufelle F: Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab. 2010, 12 (Suppl 2): 83-92.CrossRef
32.
go back to reference Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB: Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008, 7: 45-56. 10.1016/j.cmet.2007.10.013.CrossRef Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB: Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008, 7: 45-56. 10.1016/j.cmet.2007.10.013.CrossRef
33.
go back to reference Choi JS, Kim H, Jung MH, Hong S, Song J: Consumption of barley beta-glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet. Mol Nutr Food Res. 2010, 54: 1004-1013. 10.1002/mnfr.200900127.CrossRef Choi JS, Kim H, Jung MH, Hong S, Song J: Consumption of barley beta-glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet. Mol Nutr Food Res. 2010, 54: 1004-1013. 10.1002/mnfr.200900127.CrossRef
34.
go back to reference Yokoyama WH, Shao Q: Soluble fibers prevent insulin resistance in hamsters fed high saturated fat diets. Cereal Foods World. 2006, 51: 16-18. Yokoyama WH, Shao Q: Soluble fibers prevent insulin resistance in hamsters fed high saturated fat diets. Cereal Foods World. 2006, 51: 16-18.
35.
go back to reference Seyer-Hansen K: Renal hypertrophy in experimental diabetes: relation to severity of diabetes. Diabetologia. 1977, 13: 141-143. 10.1007/BF00745142.CrossRef Seyer-Hansen K: Renal hypertrophy in experimental diabetes: relation to severity of diabetes. Diabetologia. 1977, 13: 141-143. 10.1007/BF00745142.CrossRef
36.
go back to reference Banz WJ, Iqbal MJ, Bollaert M, Chickris N, James B, Higginbotham DA, Peterson R, Murphy L: Ginseng modifies the diabetic phenotype and genes associated with diabetes in the male ZDF rat. Phytomedicine. 2007, 14: 681-689. 10.1016/j.phymed.2007.06.003.CrossRef Banz WJ, Iqbal MJ, Bollaert M, Chickris N, James B, Higginbotham DA, Peterson R, Murphy L: Ginseng modifies the diabetic phenotype and genes associated with diabetes in the male ZDF rat. Phytomedicine. 2007, 14: 681-689. 10.1016/j.phymed.2007.06.003.CrossRef
37.
go back to reference Bates HE, Sirek AS, Kiraly MA, Yue JT, Goche Montes D, Matthews SG, Vranic M: Adaptation to mild, intermittent stress delays development of hyperglycemia in the Zucker diabetic Fatty rat independent of food intake: role of habituation of the hypothalamic-pituitary-adrenal axis. Endocrinology. 2008, 149: 2990-3001. 10.1210/en.2007-1473.CrossRef Bates HE, Sirek AS, Kiraly MA, Yue JT, Goche Montes D, Matthews SG, Vranic M: Adaptation to mild, intermittent stress delays development of hyperglycemia in the Zucker diabetic Fatty rat independent of food intake: role of habituation of the hypothalamic-pituitary-adrenal axis. Endocrinology. 2008, 149: 2990-3001. 10.1210/en.2007-1473.CrossRef
38.
go back to reference Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006, 29: 1357-1362. 10.2337/dc05-1801.CrossRef Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006, 29: 1357-1362. 10.2337/dc05-1801.CrossRef
39.
go back to reference Wolden-Hanson T, Marck BT, Smith L, Matsumoto AM: Cross-sectional and longitudinal analysis of age-associated changes in body composition of male Brown Norway rats: association of serum leptin levels with peripheral adiposity. J Gerontology Biol Sci Med Sci. 1999, 54: B99-B107. 10.1093/gerona/54.3.B99.CrossRef Wolden-Hanson T, Marck BT, Smith L, Matsumoto AM: Cross-sectional and longitudinal analysis of age-associated changes in body composition of male Brown Norway rats: association of serum leptin levels with peripheral adiposity. J Gerontology Biol Sci Med Sci. 1999, 54: B99-B107. 10.1093/gerona/54.3.B99.CrossRef
40.
go back to reference Wang J, Yuen VG, McNeill JH: Effect of vanadium on insulin and leptin in Zucker diabetic fatty rats. Mol Cell Biochem. 2001, 218: 93-96. 10.1023/A:1007229910582.CrossRef Wang J, Yuen VG, McNeill JH: Effect of vanadium on insulin and leptin in Zucker diabetic fatty rats. Mol Cell Biochem. 2001, 218: 93-96. 10.1023/A:1007229910582.CrossRef
41.
go back to reference Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20: 1595-1599. 10.1161/01.ATV.20.6.1595.CrossRef Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20: 1595-1599. 10.1161/01.ATV.20.6.1595.CrossRef
42.
go back to reference Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM: The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 2002, 51: 2968-2974. 10.2337/diabetes.51.10.2968.CrossRef Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM: The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 2002, 51: 2968-2974. 10.2337/diabetes.51.10.2968.CrossRef
43.
go back to reference Qi L, Rimm E, Liu S, Rifai N, Hu FB: Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care. 2005, 28: 1022-1028. 10.2337/diacare.28.5.1022.CrossRef Qi L, Rimm E, Liu S, Rifai N, Hu FB: Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care. 2005, 28: 1022-1028. 10.2337/diacare.28.5.1022.CrossRef
44.
go back to reference Sanchez D, Quinones M, Moulay L, Muguerza B, Miguel M, Aleixandre A: Soluble fiber-enriched diets improve inflammation and oxidative stress biomarkers in Zucker fatty rats. Pharmacol Res. 2011, 64: 31-35. 10.1016/j.phrs.2011.02.005.CrossRef Sanchez D, Quinones M, Moulay L, Muguerza B, Miguel M, Aleixandre A: Soluble fiber-enriched diets improve inflammation and oxidative stress biomarkers in Zucker fatty rats. Pharmacol Res. 2011, 64: 31-35. 10.1016/j.phrs.2011.02.005.CrossRef
45.
go back to reference Tishinsky JM, Robinson LE, Dyck DJ: Insulin-sensitizing properties of adiponectin. Biochimie. 2012, 94 (2): 269-276. 10.1016/j.biochi.2011.11.001.CrossRef Tishinsky JM, Robinson LE, Dyck DJ: Insulin-sensitizing properties of adiponectin. Biochimie. 2012, 94 (2): 269-276. 10.1016/j.biochi.2011.11.001.CrossRef
46.
go back to reference Forcheron F, Abdallah P, Basset A, del Carmine P, Haffar G, Beylot M: Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate. Obesity (Silver Spring). 2009, 17: 1381-1389. Forcheron F, Abdallah P, Basset A, del Carmine P, Haffar G, Beylot M: Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate. Obesity (Silver Spring). 2009, 17: 1381-1389.
47.
go back to reference Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN: Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001, 120: 1183-1192. 10.1053/gast.2001.23256.CrossRef Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN: Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001, 120: 1183-1192. 10.1053/gast.2001.23256.CrossRef
48.
go back to reference Willner IR, Waters B, Patil SR, Reuben A, Morelli J, Riely CA: Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol. 2001, 96: 2957-2961. 10.1111/j.1572-0241.2001.04667.x.CrossRef Willner IR, Waters B, Patil SR, Reuben A, Morelli J, Riely CA: Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol. 2001, 96: 2957-2961. 10.1111/j.1572-0241.2001.04667.x.CrossRef
49.
go back to reference Cassader M, Gambino R, Musso G, Depetris N, Mecca F, Cavallo-Perin P, Pacini G, Rizzetto M, Pagano G: Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids. 2001, 36: 1117-1124. 10.1007/s11745-001-0822-5.CrossRef Cassader M, Gambino R, Musso G, Depetris N, Mecca F, Cavallo-Perin P, Pacini G, Rizzetto M, Pagano G: Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids. 2001, 36: 1117-1124. 10.1007/s11745-001-0822-5.CrossRef
50.
go back to reference Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M: Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab. 2005, 90: 3498-3504. 10.1210/jc.2004-2240.CrossRef Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M: Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab. 2005, 90: 3498-3504. 10.1210/jc.2004-2240.CrossRef
51.
go back to reference Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond). 2002, 103: 137-142. 10.1042/CS20010336.CrossRef Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond). 2002, 103: 137-142. 10.1042/CS20010336.CrossRef
52.
go back to reference Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J: Beyond insulin resistance in NASH: TNF-alpha or adiponectin?. Hepatology. 2004, 40: 46-54.CrossRef Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J: Beyond insulin resistance in NASH: TNF-alpha or adiponectin?. Hepatology. 2004, 40: 46-54.CrossRef
53.
go back to reference Targher G, Bertolini L, Scala L, Poli F, Zenari L, Falezza G: Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals. Clin Endocrinol. 2004, 61: 700-703. 10.1111/j.1365-2265.2004.02151.x.CrossRef Targher G, Bertolini L, Scala L, Poli F, Zenari L, Falezza G: Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals. Clin Endocrinol. 2004, 61: 700-703. 10.1111/j.1365-2265.2004.02151.x.CrossRef
54.
go back to reference Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA: Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology. 2007, 133: 496-506. 10.1053/j.gastro.2007.04.068.CrossRef Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA: Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology. 2007, 133: 496-506. 10.1053/j.gastro.2007.04.068.CrossRef
55.
go back to reference Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003, 423: 762-769. 10.1038/nature01705.CrossRef Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003, 423: 762-769. 10.1038/nature01705.CrossRef
56.
go back to reference Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002, 8: 1288-1295. 10.1038/nm788.CrossRef Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002, 8: 1288-1295. 10.1038/nm788.CrossRef
57.
go back to reference McGarry JD, Brown NF: The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 1997, 244: 1-14. 10.1111/j.1432-1033.1997.00001.x.CrossRef McGarry JD, Brown NF: The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 1997, 244: 1-14. 10.1111/j.1432-1033.1997.00001.x.CrossRef
58.
go back to reference Stefanovic-Racic M, Perdomo G, Mantell BS, Sipula IJ, Brown NF, O'Doherty RM: A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am J Physiol Endocrinol Metabolis. 2008, 294: E969-E977. 10.1152/ajpendo.00497.2007.CrossRef Stefanovic-Racic M, Perdomo G, Mantell BS, Sipula IJ, Brown NF, O'Doherty RM: A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am J Physiol Endocrinol Metabolis. 2008, 294: E969-E977. 10.1152/ajpendo.00497.2007.CrossRef
59.
go back to reference Lochhead PA, Salt IP, Walker KS, Hardie DG, Sutherland C: 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes. 2000, 49: 896-903. 10.2337/diabetes.49.6.896.CrossRef Lochhead PA, Salt IP, Walker KS, Hardie DG, Sutherland C: 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes. 2000, 49: 896-903. 10.2337/diabetes.49.6.896.CrossRef
60.
go back to reference Bartley GE, Yokoyama W, Young SA, Anderson WH, Hung SC, Albers DR, Langhorst ML, Kim H: Hypocholesterolemic effects of hydroxypropyl methylcellulose are mediated by altered gene expression in hepatic bile and cholesterol pathways of male hamsters. J Nutr. 2010, 140: 1255-1260. 10.3945/jn.109.118349.CrossRef Bartley GE, Yokoyama W, Young SA, Anderson WH, Hung SC, Albers DR, Langhorst ML, Kim H: Hypocholesterolemic effects of hydroxypropyl methylcellulose are mediated by altered gene expression in hepatic bile and cholesterol pathways of male hamsters. J Nutr. 2010, 140: 1255-1260. 10.3945/jn.109.118349.CrossRef
61.
go back to reference Watt MJ, Hoy AJ: Lipid metabolism in skeletal muscle: generation of adaptive and maladaptive intracellular signals for cellular function. Am J Physiol Endocrinol Metab. 2012, 302: E1315-E1328. 10.1152/ajpendo.00561.2011.CrossRef Watt MJ, Hoy AJ: Lipid metabolism in skeletal muscle: generation of adaptive and maladaptive intracellular signals for cellular function. Am J Physiol Endocrinol Metab. 2012, 302: E1315-E1328. 10.1152/ajpendo.00561.2011.CrossRef
62.
go back to reference Muoio DM: Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?. Biochim Biophys Acta. 2010, 1801: 281-288. 10.1016/j.bbalip.2009.11.007.CrossRef Muoio DM: Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?. Biochim Biophys Acta. 2010, 1801: 281-288. 10.1016/j.bbalip.2009.11.007.CrossRef
63.
go back to reference Muoio DM, Koves TR: Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease. Appl Physiol Nutr Metab. 2007, 32: 874-883. 10.1139/H07-083.CrossRef Muoio DM, Koves TR: Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease. Appl Physiol Nutr Metab. 2007, 32: 874-883. 10.1139/H07-083.CrossRef
64.
go back to reference Adams SH, Hoppel CL, Lok KH, Zhao L, Wong SW, Minkler PE, Hwang DH, Newman JW, Garvey WT: Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr. 2009, 139: 1073-1081. 10.3945/jn.108.103754.CrossRef Adams SH, Hoppel CL, Lok KH, Zhao L, Wong SW, Minkler PE, Hwang DH, Newman JW, Garvey WT: Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr. 2009, 139: 1073-1081. 10.3945/jn.108.103754.CrossRef
Metadata
Title
Hydroxypropyl methylcellulose, a viscous soluble fiber, reduces insulin resistance and decreases fatty liver in Zucker Diabetic Fatty rats
Authors
David A Brockman
Xiaoli Chen
Daniel D Gallaher
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2012
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-9-100

Other articles of this Issue 1/2012

Nutrition & Metabolism 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine